Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Roxatidine Acetate
2. Roxatidine Acetate Hydrochloride
3. Roxiwas
4. Zarocs
1. 78273-80-0
2. Desacetyl-tzu-0460
3. 2-hydroxy-n-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]acetamide
4. Iv9vht3yum
5. Roxatidine (inn)
6. Roxatidine [inn]
7. Roxatidine [inn:ban]
8. Unii-iv9vht3yum
9. 2-hydroxy-n-(3-(3-(piperidin-1-ylmethyl)phenoxy)propyl)acetamide
10. 2-hydroxy-n-{3-[3-(1-piperidinylmethyl)phenoxy]propyl}acetamide
11. 2-hydroxy-n-(3-(3-(1-piperidinylmethyl)phenoxy)propyl)acetamide
12. Roxit (tn)
13. 2-hydroxy-n-[3-[3-(1-piperidylmethyl)phenoxy]propyl]acetamide
14. Roxatidine [vandf]
15. Schembl1394
16. Roxatidine [who-dd]
17. Chembl4802233
18. Dtxsid30228937
19. Bcp13552
20. Zinc1541892
21. Acetamide, 2-hydroxy-n-(3-(3-(1-piperidinylmethyl)phenoxy)propyl)-
22. Mfcd00871807
23. Akos015896584
24. Sy293181
25. Hy-137941
26. Cs-0143056
27. Ft-0756141
28. D08494
29. 273r800
30. L012909
31. Q415039
32. Sr-01000944538
33. Sr-01000944538-1
34. N-[3-[3-(1-piperidinylmethyl)phenoxy]propyl]hydroxyacetamide
| Molecular Weight | 306.4 g/mol |
|---|---|
| Molecular Formula | C17H26N2O3 |
| XLogP3 | 1.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 8 |
| Exact Mass | 306.19434270 g/mol |
| Monoisotopic Mass | 306.19434270 g/mol |
| Topological Polar Surface Area | 61.8 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 319 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Histamine H2 Antagonists
Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. (See all compounds classified as Histamine H2 Antagonists.)
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
A - Alimentary tract and metabolism
A02 - Drugs for acid related disorders
A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)
A02BA - H2-receptor antagonists
A02BA06 - Roxatidine
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Roxatidine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Roxatidine, including repackagers and relabelers. The FDA regulates Roxatidine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Roxatidine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Roxatidine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Roxatidine supplier is an individual or a company that provides Roxatidine active pharmaceutical ingredient (API) or Roxatidine finished formulations upon request. The Roxatidine suppliers may include Roxatidine API manufacturers, exporters, distributors and traders.
click here to find a list of Roxatidine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Roxatidine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Roxatidine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Roxatidine GMP manufacturer or Roxatidine GMP API supplier for your needs.
A Roxatidine CoA (Certificate of Analysis) is a formal document that attests to Roxatidine's compliance with Roxatidine specifications and serves as a tool for batch-level quality control.
Roxatidine CoA mostly includes findings from lab analyses of a specific batch. For each Roxatidine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Roxatidine may be tested according to a variety of international standards, such as European Pharmacopoeia (Roxatidine EP), Roxatidine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Roxatidine USP).
LOOKING FOR A SUPPLIER?
